x
Filter:
Filters applied
- Editor
- Anti-Müllerian hormoneRemove Anti-Müllerian hormone filter
- Fertility preservationRemove Fertility preservation filter
Editor's Choice
1 Results
- Article
Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment
Reproductive BioMedicine OnlineVol. 34Issue 6p557–566Published online: March 21, 2017- Chloë De Roo
- Sylvie Lierman
- Kelly Tilleman
- Karen Peynshaert
- Kevin Braeckmans
- Mirte Caanen
- and others
Cited in Scopus: 86Female-to-male transgender people (trans men), are faced with the risk of losing their reproductive potential owing to gender affirming hormone treatment and genital reconstructive surgery. Transgender people also tend to start sex reassignment treatment at a young age, when reproductive wishes are not yet clearly defined nor fulfilled (De Sutter, 2001). About one-half of trans men, however, express the desire to have children (Wierckx et al., 2012). It is, therefore, recommended by the most recent Standards of Care of the World Professional Association for Transgender Health to clearly discuss fertility and fertility preservation before any treatment (Coleman et al., 2012).